Intrahepatic mass-forming cholangiocarcinoma and solitary hypovascular liver metastases: is the differential diagnosis using diffusion-weighted MRI possible?

Background Intrahepatic mass-forming cholangiocellular carcinoma (IMC) is the second most common primary liver tumor. The differentiation between IMC and solitary hypovascular liver metastases (SHLM) represents a diagnostic challenge due to many overlapping magnetic resonance imaging (MRI) features. Purpose To determine the value of diffusion-weighted imaging (DWI) in addition to conventional MRI for the distinction between intrahepatic mass-forming cholangiocarcinoma and solitary hypovascular liver metastases. Material and Methods Fifty-three patients with pathologically proven IMC (n = 31) and SHLM (n = 22) who had undergone MRI and DWI before surgery or percutaneous biopsy were enrolled in this study. The following MRI features were analyzed: the size and shape of the lesion, presence of capsular retraction and segmental biliary dilatation, T2-weighted (T2W) signal intensity, the presence of target sign on DWI and enhancement pattern. Apparent diffusion coefficient (ADC) values were calculated for each lesion (b = 800 s/mm2). Univariate and multivariate logistic regression analyses were used to identify significant differentiating features between IMCs and SHLMs. Results Univariate analysis revealed that following parameters favor diagnosis of IMCs over SHLMs: lobulating shape, heterogeneous T2W signal intensity, capsular retraction, segmental biliary dilatation, target sign on DWI and rim-like enhancement on arterial phase followed by progressive enhancement in delayed phases. ADC values measured in the periphery of the lesion were significantly lower in IMCs in comparison to SHLMs. Multivariate analysis revealed that target sign on DWI was the most significant predictor of IMCs. Conclusion Qualitative DWI analysis with target sign significantly improves diagnostic accuracy for differentiation among IMC and SHLM lesions.

[1]  Hyeon Je Cho,et al.  Varying appearances of cholangiocarcinoma: radiologic-pathologic correlation. , 2009, Radiographics : a review publication of the Radiological Society of North America, Inc.

[2]  R Sinkus,et al.  [Diffusion-weighted MR imaging of the liver]. , 2010, Journal de radiologie.

[3]  I. Kovalszky,et al.  Agrin immunohistochemistry facilitates the determination of primary versus metastatic origin of liver carcinomas. , 2010, Human pathology.

[4]  Young Kon Kim,et al.  Comparison of diffuse hepatocellular carcinoma and intrahepatic cholangiocarcinoma using sequentially acquired gadolinium-enhanced and Resovist-enhanced MRI. , 2009, European journal of radiology.

[5]  M. Haider,et al.  Intrahepatic bile duct dilatation due to liver metastases from colorectal carcinoma. , 2009, AJR. American journal of roentgenology.

[6]  Myeong-Jin Kim,et al.  Gadoxetate disodium-enhanced MRI of mass-forming intrahepatic cholangiocarcinomas: imaging-histologic correlation. , 2013, AJR. American journal of roentgenology.

[7]  I. Okayasu,et al.  Cellular and stromal characteristics in the scirrhous hepatocellular carcinoma: Comparison with hepatocellular carcinomas and intrahepatic cholangiocarcinomas , 2005, Pathology international.

[8]  M. Kanematsu,et al.  Spectrum of MRI appearances of untreated metastases of the liver. , 2003, AJR. American journal of roentgenology.

[9]  R. Lenzi,et al.  The biology of unknown primary tumors. , 1993, Seminars in oncology.

[10]  T. Pawlik,et al.  Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. , 2014, Journal of hepatology.

[11]  Y. Nakanuma,et al.  Cytokeratin profile relates to histological subtypes and intrahepatic location of intrahepatic cholangiocarcinoma and primary sites of metastatic adenocarcinoma of liver , 2000, Histopathology.

[12]  Eun Sun Lee,et al.  Differentiation of intrahepatic mass-forming cholangiocarcinoma from hepatocellular carcinoma on gadoxetic acid-enhanced liver MR imaging , 2016, European Radiology.

[13]  R. Semelka,et al.  Mass-forming cholangiocarcinoma and adenocarcinoma of unknown primary: can they be distinguished on liver MRI? , 2014, Abdominal Imaging.

[14]  Young Kon Kim,et al.  Scirrhous Hepatocellular Carcinoma on Gadoxetic Acid–Enhanced Magnetic Resonance Imaging and Diffusion-Weighted Imaging: Emphasis on the Differentiation of Intrahepatic Cholangiocarcinoma , 2013, Journal of computer assisted tomography.

[15]  Noriyuki Moriyama,et al.  Detection and characterization of focal hepatic lesions with diffusion-weighted MR imaging: a pictorial review , 2013, Abdominal Imaging.

[16]  A. Dohan,et al.  Intrahepatic and hilar mass-forming cholangiocarcinoma: Qualitative and quantitative evaluation with diffusion-weighted MR imaging. , 2015, European journal of radiology.

[17]  O. Farges,et al.  Resection of intrahepatic cholangiocarcinoma: a Western experience. , 1999, Journal of hepato-biliary-pancreatic surgery.

[18]  Young Kon Kim,et al.  Diagnostic Accuracy and Sensitivity of Diffusion-Weighted and of Gadoxetic Acid-Enhanced 3-T MR Imaging Alone or in Combination in the Detection of Small Liver Metastasis (⩽1.5 cm in Diameter) , 2012, Investigative radiology.

[19]  N. Pavlidis,et al.  Cancer of unknown primary site , 2012, The Lancet.

[20]  J. H. Lim,et al.  Cholangiocarcinoma: morphologic classification according to growth pattern and imaging findings. , 2003, AJR. American journal of roentgenology.

[21]  J. Konishi,et al.  MR imaging of intrahepatic cholangiocarcinoma with pathologic correlation. , 2001, AJR. American journal of roentgenology.

[22]  H. Kressel,et al.  Hepatic colorectal metastases: correlation of MR imaging and pathologic appearance. , 1991, Radiology.

[23]  K. Kumamoto,et al.  Significance of hepatic lymph node metastasis in patients with unresectable synchronous liver metastasis of colorectal cancer. , 2011, International surgery.

[24]  B. Choi,et al.  Intrahepatic mass-forming cholangiocarcinomas: enhancement patterns at multiphasic CT, with special emphasis on arterial enhancement pattern--correlation with clinicopathologic findings. , 2011, Radiology.

[25]  D. Collins,et al.  Diffusion-weighted MRI in the body: applications and challenges in oncology. , 2007, AJR. American journal of roentgenology.

[26]  R. Reznek,et al.  Cancer of unknown primary site. , 2008, Clinical medicine.

[27]  R. Semelka,et al.  Liver metastases from unknown primary site: demonstration on MR images. , 2003, Magnetic resonance imaging.

[28]  J. M. Lee,et al.  Imaging of intrahepatic and hilar cholangiocarcinoma , 2004, Abdominal Imaging.

[29]  D. Bluemke,et al.  CT of hepatic tumors: prevalence and specificity of retraction of the adjacent liver capsule. , 1994, AJR. American journal of roentgenology.

[30]  I. Choo,et al.  Radiologic spectrum of cholangiocarcinoma: emphasis on unusual manifestations and differential diagnoses. , 2001, Radiographics : a review publication of the Radiological Society of North America, Inc.

[31]  Bachir Taouli,et al.  Diffusion-weighted MR imaging for liver lesion characterization: a critical look. , 2012, Radiology.

[32]  Young Kon Kim,et al.  Small intrahepatic mass-forming cholangiocarcinoma: target sign on diffusion-weighted imaging for differentiation from hepatocellular carcinoma , 2013, Abdominal Imaging.